Metronom Health

Metronom Health is an early-stage medical device company focused on developing innovative optical enzyme continuous glucose monitoring technology for patients with diabetes. Metronom's proprietary technology is considered to provide significant improvements in accuracy, reliability, and user-friendliness within the low blood sugar range, enabling users to achieve broader adoption and easier accessibility. Established in 2010, Metronom Health has successfully developed a commercial-grade prototype of the system and completed a First-in-Human study that confirmed the performance of the technology. The company is currently at a pivotal point in its short history, integrating its focus on engineering and R&D into product development, ensuring the final product will strongly align with user needs and the concerns of those who care for them.